Apr 24, 2025 / 11:00AM GMT
Thomas Larsen - Sanofi SA - Head of Investor Relations
Hello, everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q1 2025 conference call for investors and analysts. As usual, you can find the slides on sanofi.com.
Please turn to slide number 3, please. Here, we have the usual forward-looking statements. We would like to remind you that information presented in this call contains forward-looking statements which are subject to substantial risks and uncertainties that may cause actual results to differ materially. We encourage you to read the disclaimer in our slide presentation. In addition, we refer to our new Form 20-F on file with the US SEC and our France Registration Document for a description of these risk factors.
As last quarter, financials reported are under the new reporting scope that excludes the Opella Consumer Health business. As usual, we will be making comments on our performance using constant exchange rates and other non-IFRS measures. Numbers used are in millions of euros and for Q1 2025, unless stated otherwise.
Now, please turn to
Q1 2025 Sanofi SA Earnings Call Transcript
Apr 24, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers